The Roche Digitoxin Elecsys assay (REF 3002659122) is an electrochemiluminescence immunoassay (ECLIA) reagent kit designed for the quantitative determination of digitoxin in human serum and plasma. It is intended for use on Roche Elecsys and cobas e immunoassay platforms to support therapeutic drug monitoring workflows in clinical laboratories.

Key Features
- Methodology: Electrochemiluminescence immunoassay (ECLIA) based on competitive binding principle.
- Sample types: Human serum and lithium-heparin / K2-EDTA / K3-EDTA plasma per Roche method sheet.
- Platform compatibility: Roche Elecsys and cobas e immunoassay analyzers (refer to current Roche compatibility matrix).
- Ready-to-use reagent cassette: Streptavidin-coated microparticles, biotinylated anti-digitoxin antibody and ruthenium-labeled digitoxin derivative.
- Total assay duration: Not specified in the located sources.
- Onboard stability and calibration interval: Refer to the current Roche method sheet / IFU.

Clinical Applications
- Therapeutic drug monitoring of patients receiving digitoxin therapy for cardiac indications.
- Dose adjustment support in patients with altered pharmacokinetics, including those with renal or hepatic impairment.
- Suspected toxicity assessment in symptomatic patients on cardiac glycoside therapy.
- Compliance verification in long-term cardiac glycoside management.

Product Information
- Brand: Roche
- Product: Digitoxin Elecsys
- REF / UPN: 3002659122
- Category: Roche Reagents
- Test count per kit: Not specified in the located sources.
- Storage: Refer to the current Roche method sheet / package insert for storage temperature and stability information.
- Regulatory status: Refer to local Roche representative for regulatory clearance applicable in your region.